Quizartinib is an FLT3 inhibitor. It’s used for treating AML that comes back or doesn’t respond to treatment, especially in cases with FLT3-ITD mutations. It works by stopping FLT3 signaling.
You can get the drug in two strengths: 17.7 mg and 26.5 mg tablets with a film coating. The suggested dose is 53 mg, taken once a day, but after a starting period. The drug comes in bottles with 28 tablets inside.
Reviews
There are no reviews yet.